Afon Technology, a medtech company in Wales, aims to transform diabetes management with its non-invasive glucose monitoring device, GlucowearTM. The company recently partnered with Sony UK Technology Centre for manufacturing, a key step towards bringing the device to market.
Professor at the University of Padova, explains what we need to know about taming the environmental impact of mobile networks through GREENEDGE computing
Dianne Morrison-Beedy, PhD, RN, FNAP, FAANP, FAAN and Bernadette Melnyk, PhD, APRN-CNP, FNAP, FAANP, FAAN, issue an urgent call to action when it comes to combatting sexual risk-taking and mental health issues in adolescent females.
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
A device created to identify viruses in humans, like COVID-19, has sustained 95% accuracy in results, as a significant improvement over the current rapid tests available.
Research has identified how microplastics are being found in the Antarctic, by testing seawater samples they found that paint and varnish are the most prominent source of microplastics in the region's sea.
Dr Chang-Soo Kim, Professor at Missouri University of Science and Technology, enlightens us on smart biodegradable devices that vanish when they need to
Researchers have found a method to ascertain how pollutants and other chemicals we are exposed to affect our body and health, by discovering whether a substance has biological effects in an organism.
TfL is encouraging shoppers and retailers around London to adopt greener initiatives to reduce emissions, including using click and collect, green delivery slots and grouping deliveries.
Over a quarter of a million trees are to be planted across England in an urban greening project towards natural regeneration awarded as part of National Tree Week.
The government has extended their scheme to provide free tampons, pads, and menstrual cups to ensure the accessibility of safe sanitary products for people in education.
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
